Loxapine film - IntelGenxAlternative Names: CNS Versafilm™ therapeutic; INT 0036/2012; INT 0036/2013; INT0036
Latest Information Update: 12 May 2016
Price : *
At a glance
- Originator IntelGenx Corp.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Schizophrenia
- Preclinical CNS disorders